Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression

References

• Tan S, Sun D, Wenchen P, et al. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. Mol Cancer. 2018 Sep 20;17(1):138.
   PubMed Web of Science ®Google Scholar
• Shi X, Liu Z, Liu Z, et al. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. EBioMedicine. 2018 Nov;37:177–187.
   PubMed Web of Science ®Google Scholar
• Yang Q, Tang Y, Tang C, et al. Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-?B pathway in non-small-cell lung cancer. Am J Transl Res. 2019 Jul 15;11(7):4248–4262.
   PubMed Web of Science ®Google Scholar
• Huang M-S, Liu J-Y, Xia X-B, et al. Hsa_circ_0001946 inhibits lung cancer progression and mediates cisplatin sensitivity in non-small cell lung cancer via the nucleotide excision repair signaling pathway. Front Oncol. 2019 Jun 12;9:508. .
   PubMed Web of Science ®Google Scholar
• Zhang S, Zeng X, Ding T, et al. Microarray profile of circular RNAs identifies hsa_circ_0014130 as a new circular RNA biomarker in non-small cell lung cancer. Sci Rep. 2018 Feb 13;8(1):2878.
   PubMed Web of Science ®Google Scholar
• Hang D, Zhou J, Qin N, et al. A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer. Cancer Med. 2018 Jun;7(6):2783–2791.
   PubMed Web of Science ®Google Scholar
• Wang P, Wang J, Tan H, et al. Acid-and reduction-sensitive micelles for improving the drug delivery efficacy for pancreatic cancer therapy[J]. Biomater Sci. 2018;6(5):1262–1270.
   PubMed Web of Science ®Google Scholar
• Di W, Jia H, Zhang Z, et al. Circ-PRMT5 promotes breast cancer by the miR-509-3p/TCF7L2 axis activating PI3K/AKT pathway. J Gene Med. 2020 Dec 4:e3300. DOI:10.1002/jgm.3300
   PubMed Web of Science ®Google Scholar
• Bi W, Huang J, Nie C, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of ß-catenin pathway. J Exp Clin Cancer Res. 2018 Nov 13;37(1):275.
   PubMed Web of Science ®Google Scholar
• Chen G, Shi Y, Zhang Y, et al. CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway. Onco Targets Ther. 2017 Dec 5;10:5783–5794. .
   PubMed Web of Science ®Google Scholar
• Yokoi A, Matsuzaki J, Yamamoto Y, et al. Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun. 2018 Oct 17;9(1):4319.
   PubMedGoogle Scholar
• Perdas E, Stawski R, Nowak D, et al. The role of miRNA in papillary thyroid cancer in the context of miRNA Let-7 Family. Int J Mol Sci. 2016 Jun 15;17(6). DOI:10.3390/ijms17060909.
   PubMed Web of Science ®Google Scholar
• Zhou Y-L, Li Y, Luo D-M, et al. Microstructures, mechanical and corrosion properties and biocompatibility of as extruded Mg–Mn–Zn–Nd alloys for biomedical applications[J]. Mater Sci Eng C. 2015;49: 93–100.
   PubMed Web of Science ®Google Scholar
• Chen Y, Min L, Ren C, et al. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer. PLoS One. 2017;12(2):e0171751.
   PubMed Web of Science ®Google Scholar
• Yin Z, Meng X, Li P. miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma. Gene. 2017;620:46–53.
   PubMed Web of Science ®Google Scholar
• Li T, Ding Z-L, Zheng Y-L, et al. MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis. Biomed Pharmacother. 2017 Dec;96:153–164.
   PubMed Web of Science ®Google Scholar
• Sheedy FJ. Turning 21: induction of miR-21 as a key switch in the inflammatory response. Front Immunol. 2015 Jan 29;6:19. .
   PubMed Web of Science ®Google Scholar
• Bica-Pop C, Cojocneanu-Petric R, Magdo L, et al. Overview upon miR-21 in lung cancer: focus on NSCLC. Curr Gene Ther. 2017;16(6):375–389.
   PubMedGoogle Scholar
• Xue X, Liu Y, Wang Y, et al. MiR-21 and miR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN. Oncotarget. 2016 Dec 20;7(51):84508–84519.
   PubMedGoogle Scholar
• Xu L-F, Wu Z-P, Chen Y, et al. MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One. 2014 Aug 1;9(8):e103698.
   PubMed Web of Science ®Google Scholar
• Dai L, Chen F, Zheng Y, et al. miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3ß signaling. Front Biosci (Landmark Ed). 2019 Jun 1;24:1426–1439. .
   PubMed Web of Science ®Google Scholar
• Yang Z, Fang S, Di Y, et al. Modulation of NF-?B/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin. PLoS One. 2015 Mar 23;10(3):e0121547.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen J, Ou B, et al. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Biomed Pharmacother. 2017 Sep;93:570–579.
   PubMed Web of Science ®Google Scholar
• Xu Z, Li P, Fan L, et al. The potential role of circRNA in tumor immunity regulation and immunotherapy. Front Immunol. 2018 Jan 22;9:9. .
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017 May 23;16(1):94.
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018 Feb 1;37(5):555–565.
   PubMed Web of Science ®Google Scholar
• Wei S, Zheng Y, Jiang Y, et al. The circRNA-circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine. 2019 Jun;44:182–193.
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Yang C, et al. Upregulated circRNA ARHGAP10 predicts an unfavorable prognosis in NSCLC through regulation of the miR-150-5p/GLUT-1 Axis. Mol Ther Nucleic Acids. 2019 Aug 21;18:219–231. .
   PubMedGoogle Scholar
• Chen D, Ma W, Ke Z, et al. CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression. Cell Cycle. 2018;17(16):2080–2090.
   PubMed Web of Science ®Google Scholar
• Ganju A, Khan S, Hafeez BB, et al. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017 Feb;22(2):424–432.
   PubMed Web of Science ®Google Scholar
• Zamani S, Hosseini SM, Sohrabi A. miR-21 and miR29-a: potential molecular biomarkers for HPV genotypes and cervical cancer detection. Microrna. 2019. DOI:10.2174/2211536609666191115110015
   PubMedGoogle Scholar
• Xiao T, Jie Z. MiR-21 promotes the invasion and metastasis of gastric cancer cells by activating Epithelial-Mesenchymal Transition. Eur Surg Res. 2019;60(5–6):208–218.
   PubMed Web of Science ®Google Scholar
• Zhang H, Mao F, Shen T, et al. Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer. Oncol Lett. 2017 Feb;13(2):669–676.
   PubMed Web of Science ®Google Scholar
• Lan H, Lin C-Y, Yuan H-Y, et al. Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):742–746. Chinese.
   PubMedGoogle Scholar
• Zhou B, Wang D, Sun G, et al. Effect of miR-21 on apoptosis in lung cancer cell through inhibiting the PI3K/Akt/NF-?B signaling pathway in vitro and in vivo. Cell Physiol Biochem. 2018;46(3):999–1008.
   PubMedGoogle Scholar
• Liu Z-L, Wang H, Liu J, et al. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem. 2013 Jan;372(1–2):35–45.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao H, Zhang L. Identification of the tumor suppressive function of circular RNA FOXO3 in non-small cell lung cancer through sponging miR-155. Mol Med Rep. 2018 Jun;17(6):7692–7700.
   PubMed Web of Science ®Google Scholar
• Chen L, Nan A, Zhang N, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019 Jan 21;18(1):13.
   PubMed Web of Science ®Google Scholar
• Gkountakos A, Sartori G, Falcone I, et al. PTEN in lung cancer: dealing with the problem, building on new knowledge and turning the game around. Cancers (Basel). 2019 Aug 9;11(8). DOI:10.3390/cancers11081141.
   PubMed Web of Science ®Google Scholar
• Chang H, Cai Z, Roberts TM. The mechanisms underlying PTEN loss in human tumors suggest potential therapeutic opportunities. Biomolecules. 2019 Nov 7;9(11). DOI:10.3390/biom9110713.
   Web of Science ®Google Scholar